glp 1 agonists and inflammation Central glucagon-like peptide receptor activation inhibits Toll-like receptor agonist-induced inflammation: Cell Metabolism Molecular signals underlying the anti-inflammatory

In other words, your body already makes its own version of these medications naturally

Acta Neurol Scand 2010

0.7% divided by 2.3% = 30% - is translated as a 30% relative difference when comparing one group to another

Diabetes Res Clin Pract 174:108737 Ke Z, Ma Q, Ye X, Wang Y, Jin Y, Zhao X et al (2024) Peptide GLP-1 receptor agonists: from injection to oral delivery strategies

For patients primarily seeking weight management, either with or without type 2 diabetes, higher-dose formulations such as semaglutide 2.4 mg (Wegovy) or liraglutide 3 mg (Saxenda) may be more appropriate

Back Hlscher, C (1 Aug 2024) 'Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?' Neuropharmacology , 253, 109952